ArticleACS infectious diseases2026
Pre-Exposure to Cyclosporine A Primes Paracoccidioides brasiliensis to Evade Host Immunity.
Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Paracoccidioidomycosis (PCM) is a systemic mycosis endemic to South America caused by thermodimorphic fungi of the genus Paracoccidioides, particularly P. brasiliensis. Calcineurin inhibition by cyclosporine A (CsA) perturbs fungal thermodimorphism and growth. Here, we asked whether pre-exposure of P. brasiliensis yeasts to CsA modulates host-pathogen interactions during infection. Mice infected with CsA-pre-exposed fungi exhibited significantly reduced levels of pro- and anti-inflammatory cytokines, along with decreased recruitment and activation of innate and adaptive immune cells at both time points. Although tissue inflammation and lesion areas were diminished, fungal burdens in lungs and liver were similar between groups. Importantly, yeasts recovered from lungs 72 h after infection with CsA-pretreated fungi displayed reduced in vitro colony growth, suggesting that prior CsA exposure induces a persistent slow-growth physiological state. This altered phenotype may impair effective immune recognition and inflammatory activation. As host immunosuppression was excluded in the experimental design, fungus-intrinsic phenotypes consistent with transient calcineurin pathway inhibition: altered growth/morphogenesis and putatively modified PAMP exposure that together blunt early immune activation. We interpret late-phase differences as downstream of these early pathway-dependent shifts rather than as heritable reprogramming. Overall, pre-exposure to CsA modulates P. brasiliensis-host interaction, dissociating tissue injury from fungal burden, highlights the role of calcineurin in fungal adaptation, and demonstrates how environmental exposure to bioactive compounds can influence fungal virulence and disease outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.